The development of novel vaccines for the prevention of tuberculosis is an
area of intense interest for scientific researchers, public health agencies
, and pharmaceutical manufacturers. Development of effective new vaccines d
irected against tuberculosis for use in target populations will require clo
se cooperation among several different international organizations, includi
ng regulatory agencies responsible for evaluating the safety and effectiven
ess of new biologics for human use.